Johnson & Johnson - 49 Year Stock Price History | JNJ
Historical daily share price chart and data for Johnson & Johnson since 1970 adjusted for splits. The latest closing stock price for Johnson & Johnson as of April 24, 2019 is 139.20.
- The all-time high Johnson & Johnson stock price is 146.87, which is 5.5% above the current share price.
- The Johnson & Johnson 52-week high stock price is 146.87, which is 5.5% above the current share price.
- The Johnson & Johnson 52-week low stock price is 117.08, which is 15.9% below the current share price.
- The average Johnson & Johnson stock price for the last 52 weeks is 131.78.
| Johnson & Johnson Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2019 |
134.2491 |
126.9114 |
139.9000 |
124.8947 |
139.2000 |
8.58% |
| 2018 |
130.3399 |
134.6696 |
146.8695 |
117.0848 |
128.2028 |
-5.14% |
| 2017 |
123.9321 |
109.2263 |
138.2097 |
105.3792 |
135.1436 |
24.40% |
| 2016 |
105.6799 |
92.1446 |
116.6480 |
87.8070 |
108.6323 |
15.32% |
| 2015 |
90.1058 |
93.0759 |
96.5189 |
82.5989 |
94.1988 |
1.16% |
| 2014 |
88.5894 |
78.8774 |
96.6379 |
75.0562 |
93.1204 |
17.34% |
| 2013 |
73.2503 |
59.5776 |
82.8633 |
59.4935 |
79.3627 |
34.62% |
| 2012 |
55.2784 |
53.4396 |
60.4603 |
51.0457 |
58.9552 |
10.83% |
| 2011 |
50.6018 |
49.1671 |
54.1068 |
45.5372 |
53.1962 |
9.89% |
| 2010 |
47.7566 |
48.8955 |
50.2994 |
43.8332 |
48.4079 |
-0.58% |
| 2009 |
42.9929 |
44.3570 |
49.1072 |
34.3682 |
48.6914 |
11.28% |
| 2008 |
46.7751 |
46.8810 |
52.4057 |
40.4662 |
43.7573 |
-7.77% |
| 2007 |
44.9136 |
46.0536 |
48.6521 |
41.8579 |
47.4429 |
3.61% |
| 2006 |
42.6398 |
41.7590 |
47.6548 |
38.4863 |
45.7900 |
12.44% |
| 2005 |
43.3847 |
41.7916 |
46.3077 |
40.6816 |
40.7223 |
-3.36% |
| 2004 |
36.7918 |
33.6649 |
42.3630 |
32.3991 |
42.1371 |
25.17% |
| 2003 |
33.9672 |
35.4294 |
37.7182 |
31.6099 |
33.6649 |
-2.11% |
| 2002 |
36.6488 |
37.0808 |
41.5000 |
26.6081 |
34.3920 |
-7.88% |
| 2001 |
32.6047 |
31.7913 |
38.5147 |
26.0354 |
37.3334 |
13.97% |
| 2000 |
27.6918 |
28.3972 |
32.7575 |
21.1762 |
32.7575 |
14.04% |
| 1999 |
28.8108 |
25.1790 |
32.6818 |
23.4464 |
28.7237 |
12.46% |
| 1998 |
22.7081 |
19.5552 |
27.1003 |
19.2366 |
25.5413 |
28.99% |
| 1997 |
17.8096 |
14.7433 |
20.1202 |
14.7433 |
19.8016 |
34.31% |
| 1996 |
14.2763 |
12.3003 |
15.9287 |
12.3003 |
14.7433 |
18.11% |
| 1995 |
9.9680 |
7.8079 |
13.3587 |
7.7004 |
12.4828 |
59.14% |
| 1994 |
6.5493 |
6.3270 |
7.9698 |
5.1706 |
7.8437 |
25.00% |
| 1993 |
5.8006 |
6.7543 |
6.7543 |
4.9519 |
6.2752 |
-8.93% |
| 1992 |
6.6739 |
7.5215 |
7.7983 |
5.8302 |
6.8907 |
-10.19% |
| 1991 |
5.9593 |
4.6107 |
7.7393 |
4.3222 |
7.6723 |
62.34% |
| 1990 |
4.0993 |
3.8626 |
4.7849 |
3.3543 |
4.7260 |
23.38% |
| 1989 |
3.1956 |
2.6381 |
3.8303 |
2.6381 |
3.8303 |
42.63% |
| 1988 |
2.5232 |
2.4044 |
2.7630 |
2.1657 |
2.6854 |
16.52% |
| 1987 |
2.6338 |
2.0438 |
3.2028 |
1.9746 |
2.3047 |
15.79% |
| 1986 |
1.9136 |
1.5401 |
2.2294 |
1.4175 |
1.9904 |
27.43% |
| 1985 |
1.3049 |
1.0280 |
1.6253 |
1.0135 |
1.5620 |
49.85% |
| 1984 |
0.9716 |
1.1396 |
1.1815 |
0.8008 |
1.0424 |
-8.53% |
| 1983 |
1.2575 |
1.3480 |
1.3930 |
1.0942 |
1.1396 |
-15.66% |
| 1982 |
1.0999 |
0.9735 |
1.3888 |
0.8690 |
1.3512 |
36.93% |
| 1981 |
0.8963 |
0.8626 |
1.0097 |
0.7528 |
0.9868 |
14.54% |
| 1980 |
0.6764 |
0.6447 |
0.8637 |
0.5624 |
0.8615 |
29.41% |
| 1979 |
0.5973 |
0.6066 |
0.6720 |
0.5400 |
0.6657 |
10.49% |
| 1978 |
0.6206 |
0.5994 |
0.7210 |
0.5297 |
0.6025 |
-1.78% |
| 1977 |
0.5568 |
0.6117 |
0.6134 |
0.4930 |
0.6134 |
0.43% |
| 1976 |
0.6720 |
0.6972 |
0.7446 |
0.5638 |
0.6108 |
-12.03% |
| 1975 |
0.6851 |
0.6361 |
0.7624 |
0.5652 |
0.6943 |
12.02% |
| 1974 |
0.7520 |
0.8498 |
0.9067 |
0.5743 |
0.6198 |
-27.71% |
| 1973 |
0.9019 |
0.9728 |
0.9879 |
0.7946 |
0.8574 |
-13.21% |
| 1972 |
0.8913 |
0.7372 |
0.9994 |
0.7155 |
0.9879 |
32.98% |
| 1971 |
0.6406 |
0.4295 |
0.7457 |
0.4295 |
0.7429 |
73.74% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$373.460B |
$81.581B |
|
Johnson & Johnson is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. Its Consumer segment offers products for use in the baby care, skin care, oral care, wound care, and women's health fields, nutritional and over-the-counter pharmaceutical products. The company's Pharmaceutical segment provides various products in the areas of anti-infective, antipsychotic, contraceptive, dermatology, gastrointestinal, hematology, immunology, neurology, oncology, pain management, thrombosis, vaccines, and infectious diseases. Its Medical Devices and Diagnostics segment offers electrophysiology and circulatory disease management products; orthopaedic joint reconstruction, spinal care, neurological, and sports medicine products; surgical care, aesthetics, and women's health products. Johnson & Johnson is based in New Brunswick, New Jersey.
|
